Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1645460 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $28.01Day −7.40%Mkt cap $2.7B1Y +13.9%Off 52W high −38.4%Vol (1Y) 194.1%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,143 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.3% of sh out |
| Days to cover2.2d |
| 13F net flow (QoQ)+0.07% |
| Top-10 13F concentration90.5% |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$32.7M |
| Earnings (TTM)-$19.5M |
| ROE−121.1% |
| Net margin−96.9% |
| Sales growth 3Y162.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+206.2% |
| 1Y+13.9% |
| 3Y−75.6% |
| 5Y−91.2% |
| Since incept. (ann.)−28.0% |
Total return through 2026-07-29 · series begins 2018-01-12. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)194.1% |
| Ann. volatility (3Y)144.6% |
| Sharpe (1Y)0.83 |
| Sharpe (3Y)0.28 |
| Max drawdown (1Y)−80.9% |
| Max drawdown (3Y)−95.4% |
| Beta (3Y vs SPY)2.93 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Bleichroeder LP | 6.8M | $2M | 7.20% | +0.0% |
| GC Wealth Management RIA, LLC | 4.6M | $1M | 4.89% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | $565,214 | 2.59% | new |
| Lion Point Capital, LP | 2.2M | $506,436 | 2.33% | +0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $244,800 | 1.12% | +32.5% |
| VANGUARD FIDUCIARY TRUST CO | 543,585 | $125,025 | 0.57% | new |
| Robertson Stephens Wealth Management, LLC | 478,500 | $110,007 | 0.51% | +0.0% |
| BlackRock, Inc. | 449,161 | $103,261 | 0.47% | −0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$1.08 | — | $5.7M | +1250.6% |
| 2025-12-31 | 2026-03-16 | — | — | $21.9M | +1292.3% |
| 2025-09-30 | 2025-11-12 | −$0.07 | — | $2.1M | −35.6% |
| 2025-06-30 | 2025-08-12 | −$0.09 | — | $3.0M | +11.1% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
